BDO's Health & Life Sciences Rx Podcast podcast

Knowing When to Call It Quits in Drug Development and Healthcare Innovations

0:00
34:28
15 Sekunden vorwärts
15 Sekunden vorwärts

The drug development process is costly, time consuming and laden with risk—with only 1% of drugs making it from pre-clinical all the way to market, according to Pharma Intelligence. To beat these odds, life sciences leaders must know when to continue funding a promising, new product and when to call it quits.

Tune in for insights into:

  • Why a “fast to failure” mentality is key to a successful development pipeline
  • How leaders can redivert organizational resources after ending a program
  • Why drug development failures can ultimately lead to positive outcomes

Weitere Episoden von „BDO's Health & Life Sciences Rx Podcast“